The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application

Abstract

Purpose: The purpose of the PCCTC is to accelerate the development of novel therapeutics for prostate cancer patients, both by bringing own areas of expertise and contributing substantially to the activity of the consortium in the areas of biomarker development, androgen receptor targeted therapies, aggressive variant/neuroendocrine prostate cancer, and theranostics/novel molecular imaging. Results: During the overall grant period, 163 patients were enrolled across PCCTC clinical trials, including ten trials led or co-led by UCSF.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2023
Accession Number
AD1209654

Entities

People

  • Rahul Aggarwal

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Androgen Receptors
  • Androgens
  • Biomedical Research
  • California
  • Cancer
  • Cell Physiological Processes
  • Cells
  • Clinical Trials
  • Department Of Defense
  • Detection
  • Diseases
  • Medical Personnel
  • Neoplasms
  • Oncology
  • Prostate Cancer
  • Therapy

Fields of Study

  • Medicine
  • Physics

Readers

  • Academic Conference Management
  • Neurotrauma and Rehabilitation Medicine.
  • Prostate Cancer Biology.